Adenovirus-induced hemorrhagic cystitis after CD19-targeted chimeric antigen receptor T-cell therapy in a patient with large B-cell lymphoma
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adenovirus-induced hemorrhagic cystitis after CD19-targeted chimeric antigen receptor T-cell therapy in a patient with large B-cell lymphoma
Authors
Keywords
-
Journal
Immunotherapy
Volume 15, Issue 16, Pages 1369-1374
Publisher
Future Medicine Ltd
Online
2023-09-18
DOI
10.2217/imt-2023-0111
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Confused about Confusion
- (2022) Anne M. Spanjaart et al. NEW ENGLAND JOURNAL OF MEDICINE
- Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma
- (2022) Mi Kwon et al. HAEMATOLOGICA
- Cytomegalovirus reactivation after CD19 CAR T cell therapy is clinically significant
- (2022) George Chen et al. HAEMATOLOGICA
- A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma
- (2022) Emmanuel Bachy et al. NATURE MEDICINE
- Emerging antiviral therapeutics for human adenovirus infection: Recent developments and novel strategies
- (2021) Mackenzie J. Dodge et al. ANTIVIRAL RESEARCH
- Real‐world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B‐cell lymphoma
- (2021) Gloria Iacoboni et al. Cancer Medicine
- CAR-HEMATOTOX: A model for CAR T-cell related hematological toxicity in relapsed/refractory large B-cell lymphoma
- (2021) Kai Rejeski et al. BLOOD
- Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study
- (2021) Stephen J Schuster et al. LANCET ONCOLOGY
- Recommendations for screening, monitoring, prevention, and prophylaxis of infections in adult and pediatric patients receiving CAR T-cell therapy: a position paper
- (2020) Ibai Los-Arcos et al. INFECTION
- Adenovirus persistence, reactivation, and clinical management
- (2019) Thomas Lion FEBS LETTERS
- Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- (2018) Stephen J. Schuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adenovirus Infections in Immunocompetent and Immunocompromised Patients
- (2014) T. Lion CLINICAL MICROBIOLOGY REVIEWS
- European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL-4 (2011)
- (2012) S. Matthes-Martin et al. Transplant Infectious Disease
- How I treat adenovirus in hematopoietic stem cell transplant recipients
- (2010) C. A. Lindemans et al. BLOOD
- Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type
- (2010) L. de Padua Silva et al. HAEMATOLOGICA
- LOW DOSAGE CIDOFOVIR WITHOUT PROBENECID AS TREATMENT FOR BK VIRUS HAMORRHAGIC CYSTITIS AFTER HEMOPOIETIC STEM CELL TRANSPLANT
- (2008) Maura Faraci et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More